Identification of a myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia. - Wikidata - wikimedia - TriplyDB

Identification of a myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia.

Identification of a myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia.

http://www.wikidata.org/entity/Q33560404

about

Tumor cells positive and negative for the common cancer stem cell markers are capable of initiating tumor growth and generating both progenies LPS independent activation of the pro-inflammatory receptor Trem1 by C/EBPε in granulocytes Identification of nuclear-enriched miRNAs during mouse granulopoiesis Down-regulation of the expression of CCAAT/enhancer binding protein α gene in cervical squamous cell carcinoma BCR-ABL enhances differentiation of long-term repopulating hematopoietic stem cells Tumor-initiating cells are enriched in CD44(hi) population in murine salivary gland tumor.A humanized bone marrow ossicle xenotransplantation model enables improved engraftment of healthy and leukemic human hematopoietic cells.Cancer stem cells: a stride towards cancer cure?Valproic acid induces differentiation and transient tumor regression, but spares leukemia-initiating activity in mouse models of APL.Dynamics of leukemia stem-like cell extinction in acute promyelocytic leukemia.Gain of MYC underlies recurrent trisomy of the MYC chromosome in acute promyelocytic leukemia Expression and function of PML-RARA in the hematopoietic progenitor cells of Ctsg-PML-RARA mice Cyclic AMP responsive element binding proteins are involved in 'emergency' granulopoiesis through the upregulation of CCAAT/enhancer binding protein β PML-RARA can increase hematopoietic self-renewal without causing a myeloproliferative disease in mice.The CEBPA gene is down-regulated in acute promyelocytic leukemia and its upstream promoter, but not the core promoter, is highly methylated STAT activation status differentiates leukemogenic from non-leukemogenic stem cells in AML and is suppressed by arsenic in t(6;9)-positive AML Developing ovarian cancer stem cell models: laying the pipeline from discovery to clinical intervention.Functional and structural insights into ASB2alpha, a novel regulator of integrin-dependent adhesion of hematopoietic cells Comparison of newly diagnosed and relapsed patients with acute promyelocytic leukemia treated with arsenic trioxide: insight into mechanisms of resistance.Establishment of a humanized APL model via the transplantation of PML-RARA-transduced human common myeloid progenitors into immunodeficient mice.PML-RARα enhances constitutive autophagic activity through inhibiting the Akt/mTOR pathway.The peripheral nervous system supports blood cell homing and survival in the Drosophila larva.A novel murine model of myeloproliferative disorders generated by overexpression of the transcription factor NF-E2.Preventing clonal evolutionary processes in cancer: Insights from mathematical models.Non-steady-state hematopoiesis regulated by the C/EBPβ transcription factor.Acute myeloid leukemia stem cells and CD33-targeted immunotherapy Context Matters: Distinct Disease Outcomes as a Result of Crebbp Hemizygosity in Different Mouse Bone Marrow Compartments Erythroid lineage-restricted expression of Jak2V617F is sufficient to induce a myeloproliferative disease in mice 8-CPT-cAMP/all-trans retinoic acid targets t(11;17) acute promyelocytic leukemia through enhanced cell differentiation and PLZF/RARα degradation.MPN patients harbor recurrent truncating mutations in transcription factor NF-E2 Transcription and methylation analyses of preleukemic promyelocytes indicate a dual role for PML/RARA in leukemia initiation.Co-operative leukemogenesis in acute myeloid leukemia and acute promyelocytic leukemia reveals C/EBPα as a common target of TRIB1 and PML/RARA.Single-cell analysis of mixed-lineage states leading to a binary cell fate choice.Differential requirement for wild-type Flt3 in leukemia initiation among mouse models of human leukemia.Tumor-initiating cells of breast and prostate origin show alterations in the expression of genes related to iron metabolism.ΔNp73 overexpression promotes resistance to apoptosis but does not cooperate with PML/RARA in the induction of an APL-leukemic phenotype.Interplay of protein misfolding pathway and unfolded-protein response in acute promyelocytic leukemia.Dynamics of epigenetic modifications in leukemia.Function of oncogenes in cancer development: a changing paradigm.Cancer Stem Cells: A Moving Target

P2860

Q27318628-6BAD99C3-C1B4-48E1-865D-82AF895DDB5D Q33601239-39CAD10B-30B3-41FB-8B57-14D9D265FA44 Q33713584-45BF3E4F-09CF-407B-B2A6-E875365217E7 Q33803370-BA9D0CEF-EBCA-4328-A042-4DC4922B9489 Q33806036-C1F9D6B3-3684-4DC3-BB32-657B995B2512 Q33999375-6BAC8DFC-7F09-4CA0-925A-76994936ABC9 Q34046864-A55D6635-45F3-4D7D-AF0F-27EFE50E3A3B Q34086837-BE22CBAC-0F58-4CE2-8AD1-AD5E40624F4E Q34254302-C2F91421-6DE1-4A2A-88A7-D571FFA858AC Q34287738-69F7BFAE-23E0-4202-8681-34B271F13519 Q34340593-57562E0C-5FDF-4C9C-B94D-AFA8DC7041AB Q34441594-917ADE8C-6291-4261-9590-310CC99C3639 Q34575761-396505B6-AD2B-44A3-91B3-A9EFD706B165 Q34749039-BC4B58B5-BCA8-4DFB-9640-3C4509A4CB5F Q34750625-99506EE4-7CA5-4ED9-8E92-E09EF1F200C7 Q34786642-A4099EED-0A17-4BD5-848C-211EB9C031A2 Q34968735-9CFD649E-88D1-41E2-B35B-6A3E5ADDB26B Q35182907-9DEF27AC-12FA-4160-80D4-ADD4932B0EC0 Q35230758-164356E5-69A8-445D-BE5A-32C0EC25BA67 Q35391634-675AA9A7-C9A3-42B6-B971-360980842DF3 Q35534091-6ACB0540-88AE-41D5-B371-4EFF3FB21FCF Q35567811-72773EF1-A766-4175-8F44-F7A17668F935 Q35679582-98FE8683-3924-4C37-AE57-1D6331052718 Q35895622-59DEE1BE-CC70-4888-9AFD-48F4F9688A1D Q35904180-50B41B39-D9DB-48B3-A44A-949E31B65E53 Q36058588-F27E93AD-0EB4-4F5F-8F16-C8FDAADD7315 Q36079807-6C18B960-44F3-4592-A285-36D6FB2C313F Q36216237-17B4B303-5A85-4B7D-9A9B-8A454674D216 Q36653805-B660A8CD-6CB7-4996-A11A-340C93F0F07A Q36822717-CA903648-3FC7-4984-9B61-F13A94B89B0E Q37216371-E811A31B-A020-4477-8E6C-F68DB18124B0 Q37304117-9035ADC4-F370-4868-B583-2822010446E6 Q37510607-8EA49307-B7EA-4F7B-A5E7-668887E14BDE Q37647046-0D88CA7D-9249-49A5-A743-5F7562C2659F Q37701609-94C825DE-C2FB-4CC9-8A0D-DEA35C37A99F Q37702740-9F78E4D2-A7F8-4ED5-B4A5-5C06306BD2B1 Q37775039-1E95485A-B7B7-45D3-846D-77AC31DDBB5E Q37831766-FD2418C4-738B-44D6-84E5-8312674E71E5 Q38103175-239D4C5D-92A1-481C-9437-C4BDF9D42A2E Q38126498-665DF352-45BD-47FE-AFD0-FD2F0209CFD8

P2860

Identification of a myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia.

http://www.wikidata.org/entity/Q33560404

description

2009 nî lūn-bûn

@nan

2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Identification of a myeloid co ...... acute promyelocytic leukemia.

@ast

Identification of a myeloid co ...... acute promyelocytic leukemia.

@en

Identification of a myeloid co ...... acute promyelocytic leukemia.

@nl

type

label

Identification of a myeloid co ...... acute promyelocytic leukemia.

@ast

Identification of a myeloid co ...... acute promyelocytic leukemia.

@en

Identification of a myeloid co ...... acute promyelocytic leukemia.

@nl

prefLabel

Identification of a myeloid co ...... acute promyelocytic leukemia.

@ast

Identification of a myeloid co ...... acute promyelocytic leukemia.

@en

Identification of a myeloid co ...... acute promyelocytic leukemia.

@nl

P1433

Q33560404-332FCBFD-20AF-4C2D-8169-24C5D99FEBA9

P1476

Q33560404-887442C0-1986-441F-B39B-4AC669BCE03B

P2093

Q33560404-1731555E-1E40-4713-9DBC-EAF7DF78D4C2

Q33560404-19C375A7-D602-443F-858C-6533A0961A41

Q33560404-3594C1B2-BDE3-49EF-8DAB-A02EEE97A0A2

Q33560404-4C2049B2-46EC-4869-9F2D-615A9AC72587

Q33560404-64726BFE-437C-47F9-BC00-0EB293DD2FFF

Q33560404-68B59CF3-8C69-4180-929A-625EBC14BD47

Q33560404-94C0E4CA-EE8F-4A9B-99E9-093C3D14BD81

Q33560404-A1E4F92E-9345-4AD8-BC7E-75FAEE177333

Q33560404-B779D5CB-1C97-452C-A501-AA38E0494C59

P2860

Q33560404-00525A05-7174-4A87-A67F-D5838D0CD258

Q33560404-04AA338D-9453-48D4-BD1A-5B077466771E

Q33560404-0B5B5222-BA11-406C-99BB-8179E96A70C7

Q33560404-0D64E799-F934-4EDD-85DB-0E00198347B7

Q33560404-1178C0EF-D131-4E01-A247-61191B645E99

Q33560404-13B656A3-EAE3-4C00-A9AE-35F2F5EF145C

Q33560404-176487DB-F60C-479B-8F24-59204B107144

Q33560404-19DF50EB-1715-464F-B794-54AF104BD26E

Q33560404-1A3F86E3-7169-4A4F-ADF9-9BDF82466848

Q33560404-27A992DE-5EEB-4B1B-928B-6B943E610446

P304

Q33560404-5F018C11-703C-4C97-9778-90D90141B129

P31

Q33560404-65723F0D-B233-434D-96BA-2B42C1E2C34A

P356

Q33560404-1634926E-AF26-4F20-A758-8FF624C2E4F6

P407

Q33560404-4AA8B2E8-87B6-4988-BFF6-7D1477C415D3

P433

Q33560404-F4D7D356-C79B-41BE-B6A7-27748BD2ACC4

P478

Q33560404-04F08E97-A025-4617-BABA-3F06F8C08925

P50

Q33560404-604F5DE4-D675-4803-9A0B-8584CD34DF2C

Q33560404-C07025E1-8199-46C1-A4B3-22016ECA2A9C

Q33560404-ECBF4D62-F55A-470F-B234-0A8762DF009D

P577

Q33560404-A3F0CBC3-4F9E-4806-852B-3FC6C4FB786E

P5875

Q33560404-F9C6572F-6D9C-439F-9295-75AEF76FB59F

P698

Q33560404-3FCDF1F3-AD81-426A-8278-9CB03EE33B42

P921

Q33560404-29CD94D8-3877-4CCB-9051-8AF9E795AD23

P932

Q33560404-0A9756C3-E227-4DE0-8BD8-117F19AF94E0

P356

BLOOD-2008-10-182071

P1433

P1476

Identification of a myeloid co ...... n acute promyelocytic leukemia

@en

P2093

Alexander Ebralidze

http://www.w3.org/2001/XMLSchema#string

Amy J Wagers

http://www.w3.org/2001/XMLSchema#string

Barbara A Santana-Lemos

http://www.w3.org/2001/XMLSchema#string

Donna Neuberg

http://www.w3.org/2001/XMLSchema#string

Elena Levantini

http://www.w3.org/2001/XMLSchema#string

Florence C Guibal

http://www.w3.org/2001/XMLSchema#string

Hideyo Hirai

http://www.w3.org/2001/XMLSchema#string

Meritxell Alberich-Jorda

http://www.w3.org/2001/XMLSchema#string

Pu Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia

Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

CCAAT/Enhancer binding proteins repress the leukemic phenotype of acute myeloid leukemia

Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor

The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus

Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBP alpha

A clonogenic common myeloid progenitor that gives rise to all myeloid lineages

Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia

BCL-2 cooperates with promyelocytic leukemia retinoic acid receptor alpha chimeric protein (PMLRARalpha) to block neutrophil differentiation and initiate acute leukemia.

P304

5415-5425

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2008-10-182071

http://www.w3.org/2001/XMLSchema#string

P407

P433

27

http://www.w3.org/2001/XMLSchema#string

P478

114

http://www.w3.org/2001/XMLSchema#string

P50

Eduardo Magalhães Rego

P577

2009-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26863906

http://www.w3.org/2001/XMLSchema#string

P698

19797526

http://www.w3.org/2001/XMLSchema#string

P921

P932

2798860

http://www.w3.org/2001/XMLSchema#string